These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2620357)
1. [Genetic technology of substances important from the therapeutic and diagnostic aspects]. Srsen S Cesk Pediatr; 1989 Oct; 44(10):612-4. PubMed ID: 2620357 [No Abstract] [Full Text] [Related]
2. [Therapeutic applications of genetic engineering]. Descamps JL Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529 [TBL] [Abstract][Full Text] [Related]
3. Biopharmaceuticals in China. Hu X; Ma Q; Zhang S Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435 [TBL] [Abstract][Full Text] [Related]
4. [Animal husbandry and biotechnology]. Drost M Tijdschr Diergeneeskd; 1987 Jan; 112(1):9-15. PubMed ID: 3469784 [TBL] [Abstract][Full Text] [Related]
6. [Synthetic gene technology for new vaccines]. Mäkelä PH Duodecim; 1988; 104(22):1874-80. PubMed ID: 3065068 [No Abstract] [Full Text] [Related]
7. Antibody production without animals. Stadler BM Dev Biol Stand; 1999; 101():45-8. PubMed ID: 10566774 [TBL] [Abstract][Full Text] [Related]
8. Advances in parasite control through biotechnology. Zarlenga DS J Am Vet Med Assoc; 1994 May; 204(10):1616-21. PubMed ID: 8050941 [No Abstract] [Full Text] [Related]
9. Use of hybridoma antibodies and recombinant DNA technology in protozoan vaccine development. Danforth HD; Augustine PC Avian Dis; 1986; 30(1):37-42. PubMed ID: 3460567 [TBL] [Abstract][Full Text] [Related]
10. [Use of genetic engineering methods to create viral vaccines]. Tatarov G Vet Med Nauki; 1987; 24(1):88-92. PubMed ID: 3303657 [No Abstract] [Full Text] [Related]
11. Genetically engineered vaccines: problems and promises. Brown F; Dougan G; Snary D Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113 [TBL] [Abstract][Full Text] [Related]
13. Some aspects of the preclinical safety of drugs produced by recombinant DNA technology: Japanese government regulatory position. Hayakawa T Prog Clin Biol Res; 1987; 235():15-29. PubMed ID: 3299390 [No Abstract] [Full Text] [Related]
14. ['New look' biotechnology]. de Voogd van der Straaten WA Tijdschr Diergeneeskd; 1987 Jan; 112(1):3-8. PubMed ID: 3469783 [TBL] [Abstract][Full Text] [Related]
15. Drugs versus biologicals. An immunologist's view of the therapeutic future. Nossal GJ Med J Aust; 1984 Jul; 141(2):100-4. PubMed ID: 6330507 [No Abstract] [Full Text] [Related]
17. [Engineering antibody: from laboratory to clinic]. Xiao C; Zhu X Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):341-4. PubMed ID: 11038688 [No Abstract] [Full Text] [Related]
18. Biotechnology: a selective survey. Goldsby RA Avian Dis; 1986; 30(1):3-11. PubMed ID: 3460566 [TBL] [Abstract][Full Text] [Related]
19. Humanized antibodies as potential drugs for therapeutic use. Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787 [TBL] [Abstract][Full Text] [Related]
20. Development of attenuated Salmonella strains that express heterologous antigens. Bowe F; Pickard DJ; Anderson RJ; Londoño-Arcila P; Dougan G Methods Mol Med; 2003; 87():83-100. PubMed ID: 12958451 [No Abstract] [Full Text] [Related] [Next] [New Search]